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Background: Research supports that in vitro fertilization causes anxiety and that 
anxiety can continue into the resulting pregnancy. Most women who have IVF will 
have a less invasive treatment for infertility prior to IVF; however, it is unclear if 
specific less invasive treatment cycles impact anxiety that is experienced in the 
pregnancy resulting from IVF. 
Methods: A prospective study was conducted for women who became pregnant via 
IVF, and data was collected about reported previous non-IVF treatment cycles as 
well as Pregnancy Related Anxiety Measure. Latent Class Analysis was conducted A 
p-value of ≤0.05 was considered significant.  
Results: 144 subjects participated and were highly educated, affluent, married, and 
primarily white. The LCA process yielded two groups that on average had similar 
levels on most items except for use of intra uterine insemination and/or ovarian 
stimulation. This information was used to generate four exhaustive and mutually ex-
clusive groups: Stimulation Only (stim-only), Stimulation and Intra uterine Insemi-
nation (stim-IUI), Intra uterine Insemination only (IUI only), or No Treatment (No 
Tx). ANOVA found that those in the Stim Only group had statistically significantly 
higher PRAM scores than the Stim IUI (p=0.0036), the IUI only group (p=0.05), and 
the No Tx group (p=0.0013). 
Conclusion: Women who become pregnant via IVF and had a history of non-in vitro 
fertilization cycles that only involved ovarian stimulation experienced more preg-
nancy-specific anxiety in the pregnancy that results from in vitro fertilization. 
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ifteen percent of women worldwide experi-
ence infertility during their lifetime (1). Use 
of assisted reproductive technology (ART) 
 
such as in vitro fertilization (IVF) to treat fertility 
problems continues to rise due to successes and 
advances in science (1, 2). Despite this trend, 
there is a lack of clear understanding of the psy-
chological experience especially anxiety a woman 
experiences during the pregnancy that follows 





unclear what may put women who ultimately 
achieve a pregnancy at increased risk for experi-
encing increases in anxiety in the pregnancy that 
follows successful IVF. Understanding how anxi-
ety is experienced during pregnancy is critical be-
cause of potential impact on pregnancy outcomes. 
In the general preterm birth literature, there is 
support for a positive relationship between preg-
nancy-related anxiety and preterm birth (3, 4). 
Treatment for infertility is expensive and physi- 
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cally invasive which can be repeated for months 
or years before a pregnancy is achieved, or the 
decision is made to discontinue treatment. Treat-
ment can vary greatly based on the diagnosis. 
Most couples will be offered less invasive treat-
ment options including ovulation stimulating medi-
cations with or without intra uterine insemination 
(IUI), IUI without use of medication prior to ART 
including IVF (Stevenson, Hersheberger & Bergh, 
2016) and some will seek IVF upon definitive 
diagnosis of underlying infertility cause such as 
complete blockage of fallopian tubes or severe 
male-factor infertility, thus bypassing less inva-
sive treatment options. 
Women who are being treated for infertility re-
port increasing amounts of emotional distress dur-
ing the treatment process (5) with infertility-related 
stress impacting emotional distress (6). The emo-
tional distress experienced can carry over into re-
sulting pregnancy from infertility treatment. Qual-
itative research has found that women who are 
pregnant following IVF experience their pregnan-
cies differently than women who conceive with-
out assistance, specifically, perceiving their preg-
nancies as special and hard won (7, 8). Addition-
ally, quantitative research has found increases in 
stress, particularly pregnancy-related anxiety, in 
women pregnant via IVF as compared to women 
who conceive without assistance (9).  
The process of infertility treatment can take a 
long time to navigate. One study found that the 
average time spent on fertility care was 125 hours 
in an 18-month period of time. This translated to 
15.6 working days, with the majority of time spent 
on visits with the provider. Additionally, there was 
a direct relationship between time spent on care 
and fertility-related stress (10). Data supports that 
emotional distress increases over time in treat-
ment (11). While anxiety has been shown to in-
crease during a treatment cycle of IVF and length 
of IVF treatment has been associated with in-
creases in stress (12), what is less clear is whether 
utilization of specific less invasive treatment lead-
ing up to IVF contributes to anxiety experienced 
in a resulting pregnancy. Therefore, the aim of 
this exploratory study of women in the early se-
cond trimester of a post-IVF pregnancy was to 
assess whether certain less invasive treatment op-
tions including ovarian stimulation-only cycles, 
ovarian stimulation with IUI cycles, IUI only cy-
cles, and no previous treatment affect pregnancy-
specific anxiety levels. 
 
Methods 
The study had a prospective design targeting a 
population of pregnant women via IVF. Partici-
pants were recruited upon discharge to their obste-
trician or midwife, typically at gestational week 8, 
from a large, private infertility practice in the North 
Eastern United States. Participation in the study 
commenced at gestational week 12, and women 
who expressed interest were sent several remind-
ers about participation until gestational week 18. 
Inclusion criteria were female, 25-40 years of age, 
single or twin fetus gestation between weeks 12 
and 20 gestation and ability to read and write Eng-
lish. Exclusion criteria included having a selective 
reduction in current pregnancy, and being medi-
cally or obstetrically high-risk requiring perinat-
ologist to follow the pregnancy. Between weeks 
12-18, participants logged onto the dedicated web-
site, completed consent, and answered the study 
questionnaires. Approval was obtained from the 
New York University Committee on Activities In-
volving Human Subjects, and all subjects provid-
ed informed consent prior to participation in this 
study. The analysis sample included 144 women, 
which was as many participants that the study 
team had capacity to recruit and manage. All par-
ticipants provided informed consent and submit-
ted study questionnaires.   
Subjects completed survey questions about their 
demographic data, as well as the number of previ-
ous treatment cycles for infertility prior to IVF 
including stimulated cycles (i.e. clomiphene cit-
rate or gonadotrophins) either with or without IUI, 
non-stimulated IUI cycles, or no previous treat-
ment. The demographic questionnaire included age, 
marital status, education, income, and race. Clini-
cal characteristics such as history of miscarriage, 
number of IVF cycles, and length of infertility were 
also collected. Number of miscarriages was di-
chotomized as either a history of miscarriage or 
no history of miscarriage. IVF count data was also 
recoded as either one IVF cycle or more than one 
cycle. 
They were also asked about their perception of 
anxiety specific to pregnancy using the Pregnan-
cy-Related Anxiety Measure (PRAM).  The Preg-
nancy-Related Anxiety Measure (PRAM) (13) is a 
5-item scale assessed maternal fears and anxiety 
related to the health of the baby and the labor and 
delivery process and confidence in the obstetri-
cian and other health care providers. The revised 
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of an expanded set of items 48 that was used to 
assess the extent to which women worry or feel 
concerned about their health, their baby’s health, 
labor and delivery, and caring for the baby. The 
pregnancy-related anxiety score ranged from 10-
40, with a higher score indicating more pregnan-
cy-related anxiety. The internal reliability of the 
scale was found to be acceptable (Cronbach’s α= 
0.78). 
Descriptive statistics were used to summarize the 
demographic and clinical characteristics of the 
sample. In order to explore groups of subjects in 
the database, Latent Class Analysis (LCA) was 
conducted to identify patterns with the group def-
inition variables. Unlike standard clustering tech-
niques, LCA allows for statistical testing of model 
fit and class membership is probabilistic, with 
membership probabilities computed from the es-
timated model parameters. In the initial step of the 
analyses, increasingly complex models (adding 
more latent classes) were estimated to determine 
the optimal number of latent classes to fit the data. 
Following standard practice, the optimal number 
of latent classes was determined by comparing the 
Bayesian Information Criterion (BIC) of the can-
didate models, as well as applying substantive in-
terpretability and clinical judgment to select be-
tween candidate models (i.e., Do the classes de-
fined by a given model possess a more discernible 
clinical significance or meaning than those de-
fined by another model?). 
As described below, the LCA process yielded 2 
classes of subjects which on average agreed on all 
response items except for use of IUI and/or ovari-
an stimulation. Post hoc to the LCA process, four 
analytic groups were developed: Stim Only, Stim 
IUI, IUI only, or No Tx.   
Groups were evaluated for differences in PRAM 
levels using ANOVA. The level of significance 
was set at 0.05 for each test due the exploratory 
phase of this research. Cronbach’s alphas were 
calculated on the PRAM. 
 
Results 
Table 1 presents a summary of the demographic, 
clinical, and PRAM characteristics of the 144 
women in the early second trimester of a post-IVF 
pregnancy. The mean age was 33.5 years, (range 
of 25 to 40, SD=3.9, median=34), and the majori-
ty of the sample was Caucasian (74.8%).  Approx-
imately, 8% of the sample was Hispanic or Lati-
no. Among the 144 women, 98.6% were married 
or living with a partner, 81.3% reported having a 
bachelor's degree or higher, and 70.0% had an 
annual household income of $100K or greater. 
The mean length of infertility was 31.5 months 
(range of 3 to 168 months, SD=27.6, median=24). 
Those with months of infertility less than 12 were 
likely due to a previously identified diagnosis that 
required a clinical decision to pursue IVF without 
following traditional guidelines of waiting for 12 
months of unprotected intercourse without success 
first. Most of the women reported only one IVF 
cycle (59.0%), a negative history of miscarriage 
(61.1%), and gave birth to a singleton (72.9%). 
PRAM mean score was 20.5 (range of 10-38, SD= 
6.0, median=20.0). 
The LCA process yielded two groups that on av-
erage had similar levels on most items (age, num-
ber of IVF cycles, number of previous miscarriag-
es, previous living children, gestational size, and 
Table 1. Sample characteristics 
 
Characteristic Frequency % 
Married/Living with partner (n=144) 142 98.6% 
Education level (n=144)   
 1: High school graduate or GED 3 2.1% 
 2: Trade/Technical school/Other 9 6.2% 
 3: Associate's degree/Some college 15 10.4% 
 4:  Bachelor's degree 46 31.9% 
 5: Some graduate school 8 5.6% 
 6: Graduate/Professional degree 63 43.8% 
Income (n=143)   
 1: Under $50,000 3 2.1% 
 2: $50,000-75,000 17 11.9% 
 3: $75,001-100,000 23 16.1% 
 4: $100,001-125,000 30 21.0% 
 5: $125,001-$150,000 15 10.5% 
 6: > $150,000 55 38.5% 
Ethnicity/Race (n=143)   
 0: Black/African American 3 2.1% 
 0: Asian 23 16.1% 
 0: Other 10 7.0% 
 1: White 107 74.8% 
 Hispanic/Latino (n=143) 11 8.0% 
Miscarriage history (n=144)   
 0: No 88 61.1% 
 1: One miscarriage 28 26.4% 
 1: Two or miscarriages 18 12.5% 
Twin pregnancy (n=144)   
 0: Singleton 105 72.9% 
 1: Twins 39 27.1% 
Number of IVF cycles (n=144)   
 0: One cycle 85 59.0% 
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use of laparoscopy, amniocentesis, and saline sono-
graphy). There were two items in which they dif-
fered, use of IUI and/or ovarian stimulation. This 
information was used to generate four exhaustive 
and mutually exclusive groups: Stim Only, Stim 
IUI, IUI only, or No Tx. ANOVA found that 
those in the Stim Only group had statistically sig-
nificantly higher PRAM scores than the Stim IUI 
group (p=0.0036) and the No Tx group (p= 




The present study sought to understand if certain 
previous less invasive infertility treatments lead-
ing up to a successful IVF cycle were associated 
with increased pregnancy-related anxiety. Surpris-
ingly, the findings showed that women with a his-
tory of stimulated only cycles (i.e. clomiphene 
citrate and intercourse) had more pregnancy-
related anxiety following a successful IVF than 
women who had more complex previous treat-
ment including IUI (with or without stimulation) 
or no treatment at all.   
The subjects for this study were recruited from a 
very large Reproductive Endocrinology (RE) cen-
ter that serviced a densely populated geographic 
area in the Northeast of the U.S. Typical care for 
women with fertility concerns was to initially be 
seen by their primary women’s care provider for 
evaluation and possible treatment which could 
often include an ovulation inducing medication 
such as clomiphene citrate (14). Sometimes, these 
medications are prescribed for several cycles 
without a comprehensive medical evaluation of 
the underlying condition, and following unsuc-
cessful treatment the women are then referred on 
to the RE for complete evaluation and initiation of 
a comprehensive treatment plan. For some, a di-
agnosis of unexplained infertility is determined, 
which supports utilization of IVF instead of less 
invasive methods such as IUI with or without 
ovarian stimulation (15), therefore many of these 
women may not be treated with cycles that in-
clude IUI. While these women have a tangible 
treatment plan, those for whom no identifiable 
reason can be found for their infertility may be 
left with uncertainty about their status including 
the ability to maintain a health pregnancy. 
Uncertainty in disease processes can have a sig-
nificant role in how anxiety may manifest for in-
dividuals. The unpredictability associated with not 
Table 2. LCA results 
 
 






IUI and Clomid 
(IC) Significant pairwise tests * 
N=52 6 15 71 
Characteristic      
Age, in year (mean, sd) 33.4 (4.0) 37.8 (0.8) 30.7 (3.4) 33.8 (3.6) 
N/SO, N/I, I/SI, SO/SI, 
SO/I 
Length of infertility, in months  
(mean, sd) 
2.2 (2.3) 3.5 (4.0) 2.3 (1.9) 2.3 (2.4)  
PRAM pregnancy-related anxiety 
score (mean, sd) 
19.6 (5.6) 19.7 (4.1) 25.1 (7.5) 20.3 (5.7) N/SO, SI/SO 
Characteristic      
 Married/Living with partner (%) 98.1 100 100 98.6  
 Some graduate school or more (%) 42.3 100 53.3 59.2  
 Income at least $100,000 67.3 33.3 66.7 74.7  
 White ethnicity/Race 71.2 50.0 66.7 80.3  
Miscarriage history      
0: No 75.0 33.3 53.3 54.9  
1: One miscarriage 15.4 16.7 20.0 36.6  
Twin pregnancy      
Twins 21.2 16.7 20.0 33.8  
Number of IVF cycles      
One cycle 59.6 66.7 33.3 63.4  
 
SD=Standard deviation; PRAM=Pregnancy-Related Anxiety Scale; N=No Tx, I=IUI only, SO=Stim only, SI=Stim IUI  
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having a definitive diagnosis plays an important 
role in determining emotional responses and can 
create a reaction of sustained anxiety instead of 
short-term fear (16). For women who are experi-
encing unexplained infertility, they have already 
had many unsuccessful natural cycles before even 
liaising with medical professionals. If they con-
tinue under the care of their primary women’s 
care provider, they will experience even more cy-
cles before ultimately seeking evaluation from the 
RE. A comprehensive evaluation (17) that ulti-
mately does not find an underlying cause of the 
infertility may contribute to the feeling of unpre-
dictability. For those who ultimately achieve a 
pregnancy via IVF, they acknowledge that their 
pregnancy was very difficult to achieve and if 
something were to negatively occur, there is un-
certainty they would be able to achieve another 
(8). Women pregnant after IVF report certain ac-
tivities that underscore their belief about the fra-
gility of the pregnancy including checking for 
vaginal bleeding often and the feeling of assur-
ance after each normal ultrasound scan (18).   
When examining other literature, the uncertainty 
of the diagnosis has been evaluated in women 
with infertility issues. In one study, researchers 
found that anxiety played a significant role for 
women with unexplained infertility going through 
treatment as compared to those with a definitive 
diagnosis (19) because of a reaction to the ambig-
uous medical situation with its uncertain progno-
sis. This anxiety can change throughout the evalu-
ation and treatment process. Early on, the main 
anxiety was thought to be related to a physical 
inferiority complex, while later it was influenced 
by anxiety related to what others outside the fami-
ly say about the inability to conceive and give 
birth to a child (20). In another study examining 
the psychological experience of infertility treat-
ment over the course of several years, women ex-
perienced an acute stress response to the initial 
diagnosis and treatment plan. Emotional strain 
was higher during the first year, and then dropped 
in the second year. If treatment continued into 
year three, this strain markedly increased. Addi-
tionally, aspects of women’s personal relationship 
with partners were affected in the third year in-
cluding negatively impacting marital adjustment 
and sexual satisfaction (11). 
Not surprisingly, the ambiguity and uncertainty 
of unexplained infertility causes a higher level of 
anxiety, which has the potential to carry into the 
pregnancy. Once pregnant, women have more anx-
iety about whether the pregnancy will be success-
ful (21, 22). This may be because of a perception 
that their body is "broken" and may lead them to 
think that whatever was the roadblock to achiev-
ing a pregnancy will also affect the ability to have 
a successful birth outcome. In one qualitative study, 
women who had previous unsuccessful treatments 
were more focused on possible physical problems 
in the pregnancy (23). 
Having a better understanding of risk factors for 
anxiety experienced by women undergoing infer-
tility treatment who subsequently became preg-
nant has significant implications for improved 
clinical practice. For women still navigating the 
process of treatment, having a comprehensive un-
derstanding of how women navigate the evalua-
tion and treatment process will help providers bet-
ter meet the psychosocial needs of women, partic-
ularly those for whom no definitive cause of the 
infertility is found. It is important to appreciate 
that this study represented women who continued 
treatment through a successful IVF procedure.  A 
substantial number of couples being treated for 
fertility will discontinue fertility care before achiev-
ing pregnancy with main contributing reasons for 
withdrawal including emotional distress and poor 
prognosis (24). Only half of women with infertili-
ty will receive the treatment that is needed to 
achieve a pregnancy. One significant contributor 
for this disparity is the discontinuation of care. 
Many will stop for reasons other than poor prog-
nosis or the cost of treatment, but rather because 
of burden of treatment (22). The burden of treat-
ment is so great for many women who ultimately 
decide to pursue other avenues such as adoption 
or child-free living. Based on the results of this 
study, it is clear that there is a level of anxiety that 
is tolerable to be able to continue treatment 
through a successful IVF cycle. Additional re-
search is needed to uncover a potential threshold 
of acceptable anxiety, as well mediating and mod-
erating factors that contribute to the experience of 
anxiety during the process of infertility treatment. 
Regardless, the evidence supports that despite the 
threshold, women who have only been treated with 
ovulation induction medications still have in-
creases in anxiety about the resulting pregnancy 
following IVF. 
This is an important consideration for those car-
ing for women who become pregnant via IVF, as 
these patients may require additional emotional 
support during treatment. It has been suggested in 
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their care experience improved by minimizing the 
burden associated with the process. First, patient 
vulnerability to anxiety and other negative psy-
chosocial experiences can be improved with evi-
dence-based screening for psychological distress 
at the start of treatment and when indicated, ap-
propriate referral for support (25). Additionally, 
staff caring for women can reduce the potential 
for negative patient-staff interactions with in-
creased staff training about issues in communica-
tion/interaction skills, promoting shared decision 
making (25, 26). 
This study had limitations that should be ac-
knowledged. While current trends in clinical care 
support the notion that women have been treated 
with an ovulation induction medication such as 
clomiphene citrate prior to comprehensive evalua-
tion with the RE, the study would have benefited 
from ascertaining the specific diagnosis of women 
reporting their pregnancy-specific anxiety and 
therefore could have been incorporated into the 
data analysis, thus strengthening the findings. Al-
so, capturing the number of less invasive treat-
ment cycles subjects had prior to utilizing IVF 
would help to add dimension to the understanding 
of this phenomena. Finally, as anxiety has been 
shown to fluctuate throughout pregnancy (27), 
measuring this variable over multiple time points 
would allow for elucidation of how women who 
are pregnant via IVF experience pregnancy anxie-
ty more comprehensively.  
 
Conclusion 
This study showed that the impact of previous 
less invasive infertility treatments prior to a suc-
cessful IVF cycle was associated with increased 
pregnancy-related anxiety in the resulting preg-
nancy and women who had a history of stimulated 
only cycles (i.e. clomiphene citrate and inter-
course) previous to their successful IVF had more 
pregnancy-related anxiety during their pregnancy 
conceived via IVF than those who had more com-
plex previous treatment which included IUI (with 
or without stimulation) or no treatment at all. The 
understanding of the fact that the women who had 
only been previously treated with ovulation induc-
ing medications without IUI helps understand the 
patient care experience such that better identifica-
tion of those at risk for increased anxiety in preg-
nancy can be made, and an appropriate clinical 
response can be made for women who are experi-
encing increases in pregnancy-specific anxiety.  
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